BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Al-Haddad MA, Kowalski T, Siddiqui A, Mertz HR, Mallat D, Haddad N, Malhotra N, Sadowski B, Lybik MJ, Patel SN, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J, Catalano MF. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47:136-142. [PMID: 25314329 DOI: 10.1055/s-0034-1390742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Ren R, Krishna SG, Chen W, Frankel WL, Shen R, Zhao W, Avenarius MR, Garee J, Caruthers S, Jones D. Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation. Mod Pathol 2021;34:438-44. [PMID: 32792597 DOI: 10.1038/s41379-020-00647-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Kowalski T, Siddiqui A, Loren D, Mertz HR, Mallat D, Haddad N, Malhotra N, Sadowski B, Lybik MJ, Patel SN, Okoh E, Rosenkranz L, Karasik M, Golioto M, Linder J, Catalano MF, Al-Haddad MA. Management of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of Malignancy. J Clin Gastroenterol. 2016;50:649-657. [PMID: 27332745 DOI: 10.1097/mcg.0000000000000577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tulla KA, Maker AV. Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas. Langenbecks Arch Surg 2018;403:151-94. [DOI: 10.1007/s00423-017-1644-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
4 Faias S, Pereira L, Luís Â, Chaves P, Cravo M. Genetic testing vs microforceps biopsy in pancreatic cysts: Systematic review and meta-analysis. World J Gastroenterol 2019; 25(26): 3450-3467 [PMID: 31341368 DOI: 10.3748/wjg.v25.i26.3450] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
5 Maker AV, Hu V, Kadkol SS, Hong L, Brugge W, Winter J, Yeo CJ, Hackert T, Büchler M, Lawlor RT, Salvia R, Scarpa A, Bassi C, Green S. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential. J Am Coll Surg 2019;228:721-9. [PMID: 30794864 DOI: 10.1016/j.jamcollsurg.2019.02.040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
6 Das A, Brugge W, Mishra G, Smith DM, Sachdev M, Ellsworth E. Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy. Endosc Int Open 2015;3:E479-86. [PMID: 26528505 DOI: 10.1055/s-0034-1392016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chang YR, Park T, Park SH, Kim YK, Lee KB, Kim SW, Jang JY. Prognostic significance of E-cadherin and ZEB1 expression in intraductal papillary mucinous neoplasm. Oncotarget 2018;9:306-20. [PMID: 29416615 DOI: 10.18632/oncotarget.23012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Tsai HM, Chuang CH, Shan YS, Liu YS, Chen CY. Features associated with progression of small pancreatic cystic lesions: A retrospective study. World J Gastroenterol 2015; 21(47): 13309-13315 [PMID: 26715814 DOI: 10.3748/wjg.v21.i47.13309] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
10 Loren D, Kowalski T, Siddiqui A, Jackson S, Toney N, Malhotra N, Haddad N. Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort. Diagn Pathol 2016;11:5. [PMID: 26790950 DOI: 10.1186/s13000-016-0462-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Yip-Schneider MT, Carr RA, Wu H, Schmidt CM. Prostaglandin E2: A Pancreatic Fluid Biomarker of Intraductal Papillary Mucinous Neoplasm Dysplasia. J Am Coll Surg 2017;225:481-7. [PMID: 28739154 DOI: 10.1016/j.jamcollsurg.2017.07.521] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
12 Chiaro MD, Verbeke C. Cystic tumors of the pancreas: Opportunities and risks. World J Gastrointest Pathophysiol 2015; 6(2): 29-32 [PMID: 25977835 DOI: 10.4291/wjgp.v6.i2.29] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
13 Martin AK, Zhou Z. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of pancreatic cysts by combined cytopathology and cystic content analysis. World J Gastrointest Endosc 2015; 7(15): 1157-1169 [PMID: 26504505 DOI: 10.4253/wjge.v7.i15.1157] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
14 Bartel MJ, Raimondo M. Endoscopic Management of Pancreatic Cysts. Dig Dis Sci 2017;62:1808-15. [PMID: 28315030 DOI: 10.1007/s10620-017-4544-8] [Reference Citation Analysis]
15 Simpson RE, Yip-Schneider MT, Wu H, Fan H, Liu Z, Korc M, Zhang J, Schmidt CM. Circulating Thrombospondin-2 enhances prediction of malignant intraductal papillary mucinous neoplasm. Am J Surg 2019;217:425-8. [PMID: 30293901 DOI: 10.1016/j.amjsurg.2018.08.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Lariño-Noia J, Iglesias-Garcia J, de la Iglesia-Garcia D, Dominguez-Muñoz JE. EUS-FNA in cystic pancreatic lesions: Where are we now and where are we headed in the future? Endosc Ultrasound 2018;7:102-9. [PMID: 29667626 DOI: 10.4103/eus.eus_93_17] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
17 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochim Biophys Acta Rev Cancer 2020;1873:188318. [PMID: 31676330 DOI: 10.1016/j.bbcan.2019.188318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 Al-Haddad M. Role of emerging molecular markers in pancreatic cyst fluid. Endosc Ultrasound. 2015;4:276-283. [PMID: 26643693 DOI: 10.4103/2303-9027.170402] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
19 Arner DM, Corning BE, Ahmed AM, Ho HC, Weinbaum BJ, Siddiqui U, Aslanian H, Adams RB, Bauer TW, Wang AY, Shami VM, Sauer BG. Molecular analysis of pancreatic cyst fluid changes clinical management. Endosc Ultrasound. 2018;7:29-33. [PMID: 29451166 DOI: 10.4103/eus.eus_22_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
20 Kadayifci A, Al-Haddad M, Atar M, Dewitt JM, Forcione DG, Sherman S, Casey BW, Fernandez-Del Castillo C, Schmidt CM, Pitman MB, Brugge WR. The value of KRAS mutation testing with CEA for the diagnosis of pancreatic mucinous cysts. Endosc Int Open. 2016;4:E391-E396. [PMID: 27092317 DOI: 10.1055/s-0042-101755] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]